User profiles for Noelle K. LoConte

Noelle LoConte

Associate Professor of Medicine, University of Wisconsin, Madison
Verified email at medicine.wisc.edu
Cited by 7847

[HTML][HTML] Adjuvant chemotherapy for stage II colon cancer with poor prognostic features

ES O'Connor, DY Greenblatt, NK LoConte… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Adjuvant chemotherapy is typically considered for patients with stage II colon cancer
characterized by poor prognostic features, including obstruction, perforation, emergent …

Alcohol and cancer: a statement of the American Society of Clinical Oncology

NK LoConte, AM Brewster, JS Kaur… - Journal of Clinical …, 2018 - ascopubs.org
Alcohol drinking is an established risk factor for several malignancies, and it is a potentially
modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society …

Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients

NM Else-Quest, NK LoConte, JH Schiller… - Psychology and …, 2009 - Taylor & Francis
People who suffer from disease have often been stigmatised. The internalisation of stigma
leads to the experience of self-blame. The relationship among stigma, self-blame and …

[HTML][HTML] Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II …

…, MR Mahoney, JL Kolesar, NK LoConte… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Biliary cancers overexpress epidermal growth factor receptor (EGFR), and angiogenesis
has been correlated with poor outcome. Erlotinib, an EGFR tyrosine kinase inhibitor, …

Global epidemiology, prevention, and management of hepatocellular carcinoma

…, P Chinchilla-López, HA Torres, NK LoConte… - American Society of …, 2018 - ascopubs.org
The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …

Readmission after colectomy for cancer predicts one-year mortality

…, SM Weber, ES O'Connor, NK LoConte… - Annals of …, 2010 - journals.lww.com
Objectives: Early hospital readmission is a common and costly problem in the Medicare
population. In 2009, the Centers for Medicaid and Medicare Services began mandating hospital …

Assessment of guilt and shame in patients with non–small-cell lung cancer compared with patients with breast and prostate cancer

NK LoConte, NM Else-Quest, J Eickhoff, J Hyde… - Clinical lung cancer, 2008 - Elsevier
PURPOSE Patients with lung cancer might feel more guilt and shame resulting from previous
smoking. This study was designed to determine the levels of guilt and shame among …

Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic …

…, T Reid, E Borazanci, T Crocenzi, NK LoConte… - Clinical Cancer …, 2019 - AACR
Purpose: Limited options exist for patients with advanced pancreatic cancer progressing
after 1 or more lines of therapy. A phase II study in patients with previously treated metastatic …

Predictors of short-term postoperative survival after elective colectomy in colon cancer patients≥ 80 years of age

…, ES O'Connor, DY Greenblatt, NK LoConte… - Annals of surgical …, 2013 - Springer
Background Individuals ≥80 years of age represent an increasing proportion of colon
cancer diagnoses. Selecting these patients for elective surgery is challenging because of …

[HTML][HTML] Esophagogastric cancers: integrating immunotherapy therapy into current practice

MA Patel, JD Kratz, SJ Lubner, NK Loconte… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Immunotherapy (IO) agents have led to significant improvements in patient outcomes across
many tumor types. There have been great efforts to introduce immune checkpoint inhibitors …